G6PD and COVID-19: Contrastingly, in the very small subset of White male veterans with G6PD deficiency, we observed an approximately 3.6-fold increased likelihood of developing severe outcomes from COVID-19 in those aged at least 65 years of age compared with White male veterans aged at least 65 years who were not G6PD-deficient.